2007
EpiPen acquired from Merck
2012
Heather Bresch becomes CEO – claims EpiPen as ‘her baby’
Previously Bresch was appointed President of Mylan in
2009 and joined Mylan's Board in March 2011
2013
New strategy for EpiPen introduced based on advocacy
and marketing
2013